Guggenheim Capital LLC Organogenesis Holdings Inc. Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $8,479 - $11,727	-3,419 Reduced 14.63%	19,946 $53,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $96,058 - $196,706	-30,592 Reduced 56.7%	23,365 $75,000
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $131,298 - $225,755	27,700 Added 105.5%	53,957 $263,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $5,240 - $7,751	-810 Reduced 2.99%	26,257 $201,000
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $244,144 - $365,404	27,067 New	27,067 $250,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.